# MannKind designates Danbury facility as new corporate headquarters, plans expansion

MannKind Corporation designated its Danbury, Connecticut manufacturing and R&D facility as its new corporate headquarters, adding more than 50 jobs in 2023 and planning further expansions.

- Type: Expansion
- Announced: 2023-12-19
- Where: Danbury, Connecticut, United States
- Jobs: 50
- Status: announced
- Products: inhaled formulation treatment for pulmonary arterial hypertension
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [MannKind Corporation](https://endata.com/companies/62910.md)

## Sources

- [bdavison.bloxcms.com](https://bdavison.bloxcms.com/article_c17b0646-29eb-5b28-b4e5-26f730b14e3a.html), 2023-12-19: "MannKind CEO Michael Castagna cited planned expansions of the Danbury facility and its 'increasing strategic importance' to the company as reasons for the new designation."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
